Skip to content

PreHospital Air Medical Plasma Trial

Prehospital Air Medical Plasma (PAMPer) Phase III Multicenter, Prospective, Randomized, Open-label, Interventional Trial A Four Year Multicenter Open Label Randomized Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01818427
Acronym
PAMPer
Enrollment
523
Registered
2013-03-26
Start date
2014-05-31
Completion date
2017-09-30
Last updated
2021-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemmorhagic Shock During Air Medical Transport

Keywords

hemmorhagic shock, plasma, air medical transport, randomized, multicenter

Brief summary

To determine the effect of the prehospital infusion during air transport of 2 units of AB plasma on 30 day mortality in patients with hemorrhagic shock as compared to conventional care.

Detailed description

Background: Although advances in the care of the severely injured patient have occurred over the last decade, patients continue to be plagued with uncontrolled hemorrhage resulting in significant early mortality and the development of multiple organ failure and associated complications. A primary driving force for this unbridled hemorrhage has been shown to be the early coagulopathy which complicates severe injury. Increasing evidence suggests that blood component transfusion protocols that address this early coagulopathy, once a patient arrives at a trauma center, are associated with lower mortality and a reduction in blood component transfusion requirements. Prehospital interventions which quell this early coagulopathy in an earlier setting have the potential to minimize or even prevent this vicious hemorrhagic cascade, further lowering blood component transfusion requirements and reducing the resultant morbid sequelae which complicates severe injury. Objective/Hypothesis: The primary hypothesis will be that prehospital infusion of plasma during air medical transport in patients with hemorrhagic shock will lower 30 day mortality. The secondary hypotheses include that prehospital infusion of plasma will reduce 24 hour blood transfusion, multiple organ failure, nosocomial infection, and acute lung injury, reduce or prevent the early coagulopathy as demonstrated by improving presenting coagulation and thromboelastography parameters, and reduce the early inflammatory cytokine response, thrombomodulin and increase protein C levels.

Interventions

BIOLOGICALinfusion of 2 units of plasma

infusion of 2 units of plasma

Sponsors

University of Texas
CollaboratorOTHER
University of Louisville
CollaboratorOTHER
Vanderbilt University
CollaboratorOTHER
Case Western Reserve University
CollaboratorOTHER
The University of Tennessee, Knoxville
CollaboratorOTHER
JPS Health Network
CollaboratorOTHER
The Methodist Hospital Research Institute
CollaboratorOTHER
Jason Sperry
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Hemorrhagic shock not responsive to crystalloid infusion -

Exclusion criteria

Isolated Fall, Cervical cord injury, prisoner, pregnant patient, traumatic arrest \-

Design outcomes

Primary

MeasureTime frameDescription
Our Primary Outcome for the Proposal Will be 30 Day Mortality30 daysAll cause 30 day mortality using imputation for those with missing 30 day mortality.

Secondary

MeasureTime frameDescription
Twenty Four-Hour Blood Transfusion Requirementsat twenty four hours24-hour blood transfusion requirements will be determined by recording blood volume (mls) and number of Units transfused from the time of trauma bay arrival or upon completion of pre-hospital initiated plasma infusion. For survival bias analysis, volumes and number of blood transfusion Units received at 3, 6, 12, and 18 hours will also be recorded.
In-hospital Mortalityduring hospitalizationIn hospital mortality will be prospectively recorded from the time of trauma bay arrival. Over the first 24 hours we will document and record the time of death in hours, while after the 24 hour time point, we will document and record the time of death in days from arrival. We suspect that patients in hemorrhagic shock will have a significant percentage of mortality occurring in the first 24 hour period.
Multiple Organ Failureduring hospitalizationOrgan dysfunction will be evaluated via a well-validated scoring system referred to as the Multiple Organ Dysfunction Score (MODScore). Patients who are never admitted to the ICU or those with a length of ICU stay of less than 48 hours will be considered to have a MODScore of 0. A summary of the MODScore may be calculated by summing the worst scores of each of the individual systems over the course of the ICU stay (Table 1). A summary MODScore \> 5 will be classified as multiple organ failure (MOF). Scores will be determined daily up until post injury day 28 or ICU discharge.
Acute Lung Injury (ALI) and Transfusion Related Acute Lung Injury (TRALI)hospitalizationDevelopment of ALI will be assessed which includes: 1) bilateral infiltrates on chest x-ray, 2) a capillary wedge pressure \< 18mmHg, and 3) Pao2/Fio2 ratio \< 300 via blood gas analysis. In those patients without a Swan-Ganz catheter to determine capillary wedge pressure, the absence of signs of, or clinical concern, for elevated left sided atrial pressures will be used for the diagnosis. All patients who remain intubated beyond the first 24 hours post-injury will be evaluated using blood gas analysis and chest x-ray evaluation. Those patients who remain intubated at 48 hours through 7 days will be reevaluated for this outcome at these time points. The diagnosis of TRALI will be defined as when ALI occurs within the first 6 hours from arrival at the trauma center as it is clinically defined.

Countries

United States

Participant flow

Participants by arm

ArmCount
Plasma
infusion of 2 units of plasma infusion of 2 units of plasma: infusion of 2 units of plasma
230
Standard Air Medical Care
control group
271
Total501

Baseline characteristics

CharacteristicPlasmaTotalStandard Air Medical Care
Age, Continuous44 years45 years46 years
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
14 Participants43 Participants29 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
9 Participants22 Participants13 Participants
Race (NIH/OMB)
White
207 Participants435 Participants228 Participants
Region of Enrollment
United States
230 Participants501 Participants271 Participants
Sex: Female, Male
Female
66 Participants137 Participants71 Participants
Sex: Female, Male
Male
164 Participants364 Participants200 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
53 / 22089 / 261
other
Total, other adverse events
5 / 2202 / 261
serious
Total, serious adverse events
1 / 2202 / 261

Outcome results

Primary

Our Primary Outcome for the Proposal Will be 30 Day Mortality

All cause 30 day mortality using imputation for those with missing 30 day mortality.

Time frame: 30 days

Population: 10 patients in each arm were lost to follow-up for 30-day mortality and 22 patients total, 8 in the plasma arm and 12 in the standard care arm withdrew consent and 1 patient in each arm was a prisoner and could not be included in the analysis cohort. We compared 30-day mortality using a two sided pooled z test with continuity correction.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PlasmaOur Primary Outcome for the Proposal Will be 30 Day Mortality53 Participants
Standard Air Medical CareOur Primary Outcome for the Proposal Will be 30 Day Mortality89 Participants
Secondary

Acute Lung Injury (ALI) and Transfusion Related Acute Lung Injury (TRALI)

Development of ALI will be assessed which includes: 1) bilateral infiltrates on chest x-ray, 2) a capillary wedge pressure \< 18mmHg, and 3) Pao2/Fio2 ratio \< 300 via blood gas analysis. In those patients without a Swan-Ganz catheter to determine capillary wedge pressure, the absence of signs of, or clinical concern, for elevated left sided atrial pressures will be used for the diagnosis. All patients who remain intubated beyond the first 24 hours post-injury will be evaluated using blood gas analysis and chest x-ray evaluation. Those patients who remain intubated at 48 hours through 7 days will be reevaluated for this outcome at these time points. The diagnosis of TRALI will be defined as when ALI occurs within the first 6 hours from arrival at the trauma center as it is clinically defined.

Time frame: hospitalization

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PlasmaAcute Lung Injury (ALI) and Transfusion Related Acute Lung Injury (TRALI)48 Participants
Standard Air Medical CareAcute Lung Injury (ALI) and Transfusion Related Acute Lung Injury (TRALI)50 Participants
Secondary

In-hospital Mortality

In hospital mortality will be prospectively recorded from the time of trauma bay arrival. Over the first 24 hours we will document and record the time of death in hours, while after the 24 hour time point, we will document and record the time of death in days from arrival. We suspect that patients in hemorrhagic shock will have a significant percentage of mortality occurring in the first 24 hour period.

Time frame: during hospitalization

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PlasmaIn-hospital Mortality51 Participants
Standard Air Medical CareIn-hospital Mortality88 Participants
Secondary

Multiple Organ Failure

Organ dysfunction will be evaluated via a well-validated scoring system referred to as the Multiple Organ Dysfunction Score (MODScore). Patients who are never admitted to the ICU or those with a length of ICU stay of less than 48 hours will be considered to have a MODScore of 0. A summary of the MODScore may be calculated by summing the worst scores of each of the individual systems over the course of the ICU stay (Table 1). A summary MODScore \> 5 will be classified as multiple organ failure (MOF). Scores will be determined daily up until post injury day 28 or ICU discharge.

Time frame: during hospitalization

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PlasmaMultiple Organ Failure145 Participants
Standard Air Medical CareMultiple Organ Failure156 Participants
Secondary

Twenty Four-Hour Blood Transfusion Requirements

24-hour blood transfusion requirements will be determined by recording blood volume (mls) and number of Units transfused from the time of trauma bay arrival or upon completion of pre-hospital initiated plasma infusion. For survival bias analysis, volumes and number of blood transfusion Units received at 3, 6, 12, and 18 hours will also be recorded.

Time frame: at twenty four hours

ArmMeasureValue (MEDIAN)
PlasmaTwenty Four-Hour Blood Transfusion Requirements3 units of blood
Standard Air Medical CareTwenty Four-Hour Blood Transfusion Requirements4 units of blood

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026